Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.
Changes in the sequence of two genes, EGF and EGFR, may affect the clinical development of benign prostatic hyperplasia (BPH) by influencing prostate volume and PSA levels, according to new research. ... Read more
A combination therapy composed of a 5-alpha-reductase inhibitor and an alpha-blocker provides significant improvements in men with benign prostatic hyperplasia (BPH), according to a new study. But a high ... Read more
Patients with benign prostatic hyperplasia (BPH) who are at high risk of bleeding can be safely and efficiently treated with a laser surgery called two-micrometer (2-μm) continuous laser vaporization, ... Read more
MicroRNAs present in the blood show promise as potential minimally invasive biomarkers to help doctors distinguish between prostate cancer and benign prostatic hyperplasia (BPH), new research suggests. The study, ... Read more
Measures that assess prostate volume in patients with benign prostatic hyperplasia (BPH) may be used to predict patient outcome after prostate artery embolization (PAE) surgery, researchers found. The study, ... Read more
Benign prostatic hyperplasia (BPH) patients with a history of acute urinary retention may be helped by HoLEP surgery and experience improvement in their urinary urgency, a study reports. The study, ... Read more
Treating benign prostatic hyperplasia (BPH) using a new approach to a technique called transurethral split of the prostate (TUSP) is safe and effective in the long term, according to a retrospective ... Read more